Technology & Library Transfer

MorphoSys offers the transfer and installation of the HuCAL GOLD library and the AutoCAL automated screening system at the premises of its clients, for the purpose of generating antibody reagents as well as therapeutic and diagnostic antibody candidates. This offer includes a comprehensive training for prospective users, the HuCAL user manual and a specialized customer support. In return, MorphoSys receives technology access and research license fees. For commercial use, MorphoSys also receives development milestones and royalties on end products. Technology licensing agreements currently exist with companies including Bayer Schering, Daiichi-Sankyo, Schering-Plough, Merck & Co. Inc., Shionogi and XOMA.